Surgeons at Massachusetts General Hospital have successfully performed the fourth pig kidney transplant in the United States.

Up to 50 transplant patients will receive a genetically modified pig kidney in a clinical trial that will launch this summer ...

Blood clots form in response to signals from the lungs of cancer patients -- not from other organ sites, as previously thought -- according to a preclinical study. Clots are the second-leading cause ...

Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), a $15.77 billion market cap company with an "Excellent" financial health rating according to InvestingPro, executed a ...

David-Alexandre C. Gros, MD, CEO at Eledon, discusses the milestone and the role of immunosuppression regimens for durable ...

Massachusetts General Hospital announced that Tim Andrews recovered well enough from the transplant to leave the hospital a ...

RLF-TD011 has previously received orphan drug designation (ODD) from the U.S. Food and Drug Administration (FDA) for the treatment of EB. The Company also intends to seek qualified infectious disease ...

A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...

Amazon Music and WPP unveiled Louder Than Cancer, an effort uniting top global artists to harness the power of music in recognition of World Cancer Day with creative leadership from WPP’s Grey Health, ...

A 66-year-old New Hampshire man received the kidney as part of a small pilot study at Mass General Brigham. United Therapeutics, another developer of gene-edited pig organs, just won FDA approval for ...